BR9706967A - Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa - Google Patents
Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausaInfo
- Publication number
- BR9706967A BR9706967A BR9706967A BR9706967A BR9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A BR 9706967 A BR9706967 A BR 9706967A
- Authority
- BR
- Brazil
- Prior art keywords
- menopause
- prophylaxis
- compounds
- treatment
- symptoms related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US983496P | 1996-01-11 | 1996-01-11 | |
| US67826196A | 1996-07-11 | 1996-07-11 | |
| PCT/DK1997/000008 WO1997025035A1 (en) | 1996-01-11 | 1997-01-09 | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9706967A true BR9706967A (pt) | 1999-05-04 |
Family
ID=26679921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9706967A BR9706967A (pt) | 1996-01-11 | 1997-01-09 | Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0873120A1 (ko) |
| JP (1) | JP2000506505A (ko) |
| KR (1) | KR19990077156A (ko) |
| AU (1) | AU1367297A (ko) |
| BR (1) | BR9706967A (ko) |
| CA (1) | CA2241623A1 (ko) |
| CZ (1) | CZ217298A3 (ko) |
| HU (1) | HUP9902683A3 (ko) |
| IL (1) | IL124882A0 (ko) |
| NO (1) | NO983178L (ko) |
| PL (1) | PL327831A1 (ko) |
| WO (1) | WO1997025035A1 (ko) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| DK1246814T3 (da) * | 1999-12-30 | 2005-05-30 | Signal Pharm Llc | Forbindelser og fremgangsmåder til modulation af östrogenreceptorer |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| ATE532777T1 (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie |
| WO2006042409A1 (en) | 2004-10-20 | 2006-04-27 | Endorecherche, Inc. | Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
| US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
| JP5558358B2 (ja) | 2007-10-16 | 2014-07-23 | レプロス セラピューティクス インコーポレイティド | メタボリック症候群用のｔｒａｎｓ−クロミフェン |
| US20100317635A1 (en) | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| KR20130031339A (ko) | 2010-06-16 | 2013-03-28 | 앙도르쉐르슈 인코포레이티드 | 에스트로겐-관련 질병의 치료 또는 예방 방법 |
| JP6013349B2 (ja) | 2010-11-01 | 2016-10-25 | メイ ファーマ, インク.Mei Pharma, Inc. | 癌の処置のためのイソフラボノイド化合物および方法 |
| CA2865234A1 (en) | 2012-02-29 | 2013-09-06 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
| AU2015213484B2 (en) | 2014-02-07 | 2015-11-05 | Kazia Therapeutics Limited | Functionalised benzopyran compounds and use thereof |
| US9744177B2 (en) | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
| ES2877712T3 (es) | 2015-02-02 | 2021-11-17 | Mei Pharma Inc | Terapias combinadas para su uso en el tratamiento del cáncer de mama |
| AU2016352592B2 (en) | 2015-11-10 | 2023-04-27 | Paracrine Therapeutics Ab | Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
-
1997
- 1997-01-09 AU AU13672/97A patent/AU1367297A/en not_active Abandoned
- 1997-01-09 JP JP9524768A patent/JP2000506505A/ja active Pending
- 1997-01-09 CA CA002241623A patent/CA2241623A1/en not_active Abandoned
- 1997-01-09 WO PCT/DK1997/000008 patent/WO1997025035A1/en not_active Application Discontinuation
- 1997-01-09 KR KR1019980705294A patent/KR19990077156A/ko not_active Application Discontinuation
- 1997-01-09 PL PL97327831A patent/PL327831A1/xx unknown
- 1997-01-09 BR BR9706967A patent/BR9706967A/pt not_active Application Discontinuation
- 1997-01-09 HU HU9902683A patent/HUP9902683A3/hu unknown
- 1997-01-09 IL IL12488297A patent/IL124882A0/xx unknown
- 1997-01-09 CZ CZ982172A patent/CZ217298A3/cs unknown
- 1997-01-09 EP EP97900200A patent/EP0873120A1/en not_active Withdrawn
-
1998
- 1998-07-10 NO NO983178A patent/NO983178L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL327831A1 (en) | 1999-01-04 |
| EP0873120A1 (en) | 1998-10-28 |
| NO983178L (no) | 1998-07-10 |
| HUP9902683A3 (en) | 2001-08-28 |
| CZ217298A3 (cs) | 1999-01-13 |
| KR19990077156A (ko) | 1999-10-25 |
| HUP9902683A2 (hu) | 2001-04-28 |
| CA2241623A1 (en) | 1997-07-17 |
| WO1997025035A1 (en) | 1997-07-17 |
| IL124882A0 (en) | 1999-01-26 |
| JP2000506505A (ja) | 2000-05-30 |
| AU1367297A (en) | 1997-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9706967A (pt) | Utilização de compostos e processo para tratamento e profilaxia de sintomas relacionados à menopausa | |
| BR9400571A (pt) | Processo para o tratamento de despejo orgânico | |
| PT712860E (pt) | Processo para purificacao e isolamento de 2'-deoxi-2', 2'-difluoronucleosidos | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| ITMI941252A0 (it) | Composizione catalitica e processo per l'alchilazione di composti aromatici | |
| BR9503624A (pt) | Processo de preparação de compostos aromáticos | |
| BR9408407A (pt) | Uso de inibidores pla2 como tratamento para doença de alzheimer | |
| BR9305274A (pt) | Processo para tratar leite cru | |
| BR9400177A (pt) | Processo e dispositivo para evacuação des resíduos sólidos | |
| BR9204375A (pt) | Composicao e processo para o tratamento de agua de refrigeracao | |
| BR9506271A (pt) | Processo para o tratamento de aves domésticas | |
| BR9708093A (pt) | Composto formulação uso composto e processo para tratamento de distúrbios mediados por 5-hidroxitriptamina e para preparação do composto | |
| BR9506473A (pt) | Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas | |
| BR9708607A (pt) | Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico | |
| BR9400368A (pt) | Processo para isolamento e purificação de trehalose | |
| PT96725A (pt) | Processo para o tratamento de graos de cacau | |
| BR9708908A (pt) | Processo para tratamento de inflamação | |
| BR9607346A (pt) | Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos | |
| BR9106377A (pt) | Composicao e processo para o tratamento topico de tecido lesado ou enfermo | |
| BR9505700A (pt) | Processo para e preparação contínua de isocianatos orgânicos | |
| BR9602657A (pt) | Processo para tratamento de resíduo de bauxita de lama vermelha e descarte de resíduo de lama vermelha | |
| PT1345944E (pt) | Processo para o isolamento e purificacao de epotilonas | |
| PT1068162E (pt) | Processo para remocao de impurezas de argilas de caulino | |
| BR9606766A (pt) | Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais | |
| BR9502184A (pt) | Composições cosmeticas de uso tópico utilização de composições processo de tratamento cosmético |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |